This new practice is of fundamental importance, says the Swiss Cancer League, which has been pushing for the new law for over 20 years.
“The data will make it possible to better understand the cause of the cancers, as well as to plan screening measures in a more targeted way,” Rolf Marti, head of the league’s research, innovation and development sector, said in a media releaseExternal link. “This data will also give indications on the quality of care.”
The federal law on the registration of oncological diseases requires doctors, laboratories, hospitals and health institutions to report any data relating to diagnosed cancers to cantonal registries or to the childhood cancer registry. The law obliges all cantons to finance and maintain these registers.
Data protection
Patients need not worry about confidentiality. The law guarantees that their personal data will be protected.
Two categories of information will be provided. The basic data will relate to the type and stage of the disease or the first treatment. For breast, prostate and colon cancer, additional data will be entered.
Detailed information about the course of the disease and the treatment will be collected for children and adolescents.
More
More
Heart disease and cancer still biggest causes of death
This content was published on
Cardiovascular disease and cancer were the two most widespread causes of death in Switzerland in 2017, new statistics have shown.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
Swiss researchers decode cell receptor in cancer metastasis
This content was published on
Researchers in Switzerland have deciphered the structure of a cell receptor, unlocking new hope for the prevention of metastasis of certain cancers.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.